Versican Plus DHPPi

Authorised

This medicine is authorised for use in the European Union

canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Versican Plus DHPPi : EPAR - Summary for the public

Product information

Versican Plus DHPPi : EPAR - Product Information

Versican Plus DHPPi : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Versican Plus DHPPi
• Active substance:
  canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B and canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated)
• International non-proprietary name (INN) or common name:
  canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus

Authorisation details

• EMA product number:
  EMEA/V/C/003679

Assessment history

Changes since initial authorisation of medicine

Versican Plus DHPPi : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Versican Plus DHPPi

Adopted Reference Number: EMA/CVMP/574869/2018

Initial marketing authorisation documents

Versican Plus DHPPi : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Versican Plus DHPPi

Adopted Reference Number: EMA/CVMP/229798/2014